A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis.

v1

Type:Conference Paper

0 views

[![NobleID](https://www.nobleid.org/api/badge/3E6BC908.svg?ark=w1%2F20260515%2F3E6BC908)](https://nobleid.org/work/w1/20260515/3E6BC908)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors